I am a highly trained and experienced paediatric surgeon, having worked across several of the UK’s leading centres for paediatric surgery including Birmingham and Leicester Children’s Hospitals. My clinical practice is deeply rooted in advanced surgical care for complex paediatric conditions, with a strong focus on gastrointestinal surgery, minimally invasive techniques, and multidisciplinary management of children with long-term surgical needs.

A major focus of my surgical expertise lies in the management of short bowel syndrome (SBS), where I have been extensively involved in both the acute stabilisation and long-term surgical treatment of these complex patients. I have performed a wide range of surgical bowel lengthening procedures, including Serial Transverse Enteroplasty (STEP) and Longitudinal Intestinal Lengthening and Tailoring (LILT), together with Bianchi lengthening procedures all tailored to individual patient anatomy and physiology. My management of these patients also includes the insertion and maintenance of long-term central venous access, such as tunnelled central lines and implantable ports, with close attention to infection prevention, line longevity, and nutritional planning skills all gained from working in the above high-volume centres.

In parallel, I possess advanced skills in laparoscopic paediatric surgery, having independently performed complex minimally invasive procedures including laparoscopic-assisted bowel resections, fundoplication, pull-through operations for Hirschsprung’s disease, and laparoscopic management of intra-abdominal masses. My laparoscopic practice also extends into thoracoscopic procedures, including lung resections and oesophageal surgery, with a particular interest in improving perioperative outcomes and reducing hospital stays through minimally invasive approaches.

In the field of paediatric thoracic surgery, I have acquired extensive experience in the surgical correction of pectus deformities from working in the restigeous thoracic surgery center at Birmingham Children’s Hospital, utilising both the Nuss and Ravitch techniques, frequently in collaboration with anaesthesia, physiotherapy, and respiratory teams to ensure comprehensive perioperative care.

Importantly, my oncology surgery experience includes the resection of complex intra-abdominal and retroperitoneal tumours in children, often in coordination with national paediatric oncology networks. I have also participated in paediatric liver and kidney transplant surgery, gaining proficiency in recipient procedures as well as post-operative management.

Technically adept and clinically grounded, I strive to combine surgical precision with compassionate, family-centred care. I am committed to multidisciplinary teamwork, mentoring junior colleagues, and contributing to the advancement of paediatric surgical services through innovation and service improvement. My goal is to deliver safe, effective, and evidence-based surgical care tailored to the unique needs of each child.

I am now seeking a visiting or fixed consultant paediatric surgery post where I can further contribute my skills in complex gastrointestinal, transplant, and minimally invasive surgery. I am confident in my ability to make a significant impact both clinically and as part of a forward-thinking surgical team.

• Surgical Oncology
• Oncology
• Paediatric Surgery

• M Alabdullah, A Alblihy, R Ali, S Chan, S Madhusudan, E Rakha. Human Ligase 3 (LIG3) Impact on Primary Surgically Resected Epithelial Ovarian Cancer is Dependent on its Cellular Sub-localisation – Clinical and Preclinical Evaluation. Clinics in Oncology Journal, 1.92, Jan 2022; ISSN: 2474-1663. DOI: https://www.clinicsinoncology.com/open-access/human-ligase-3-lig3-impact-on-primary-surgicallynbspresected-epithelial-8413.pdf
• M Alabdullah, I Miligy, A Alblihy, R Ali, M Toss, S Chan, S Madhusudan, E Rakha. DNA Damage Repair Proteins (PARP1, XRCC1 and POLβ) have Unfavorable Potential Prognostic Role in Primary Ovarian Cancer. Clinics in Oncology Journal, 1.92, Oct 2021; ISSN: 2474-1663. DOI: http://www.clinicsinoncology.com/open-access/dna-damage-repair-proteins-parp1-xrcc1-and-polbetanbsp-8128.pdf
• R Ali, M Alabdullah* (First joint author), M Algethami, A Alblihy, I Miligy, A Shoqafi, K Mesquita, T Abdel-Fatah, S Chan, P Chiang, N Mongan, E Rakha, A Tomkinson, S Madhusudan. Ligase 1 is a Predictor of Platinum Resistance and its Blockade is Synthetically Lethal in XRCC1 Deficient Epithelial Ovarian Cancers. Theranostics Journal, 11.56, Jul 2021; PMCID: PMC8344016. DOI: 10.7150/thno.51456. https://pubmed.ncbi.nlm.nih.gov/34373746/
• M Alabdullah, I Miligy, A Alblihy, R Ali, M Toss, S Chan, S Madhusudan, E Rakha. The Prognostic Significance of the Signalling Proteins: PTEN, P85α, ATM and XIAP in Primary Ovarian Cancer. Clinics in Oncology Journal, 1.92, May 2021; ISSN: 2474-1663. DOI: http://www.clinicsinoncology.com/open-access/the-prognostic-significance-of-the-signaling-proteinsnbsppten-p85-6924.pdf
• R Ali, A Alblihy, I Miligy, M Alabdullah, M Alsaleem, M Toss, M Algethami, T Abdel-Fatah, P Moseley, S Chan, N Mongan, S Narayan, E Rakha, S Madhusudan. Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers. Oncogene Journal, IF 9.867, Mar 2021; PMCID: PMC8032555. DOI: 10.1038/s41388-021-01710-y. https://pubmed.ncbi.nlm.nih.gov/33674744/
• A Alblihy, M Alabdullah, R Ali, M Algethami, M Toss, N Mongan, E Rakha, S Madhusudan. Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian Cancers. Biomedicines Journal, IF 5.61, Jan 2021; PMCID: PMC7826685. DOI: 10.3390/biomedicines9010056. https://pubmed.ncbi.nlm.nih.gov/33435622/
• A Alblihy, M Alabdullah, M Toss, M Algethami, N Mongan, E Rakha, S Madhusudan. RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers. Molecular Biomedicine Journal, IF 6.354, 2020; DOI: https://doi.org/10.1186/s43556-020-00023-y
• R Ali, M Alabdullah, I Miligy, M Normatova, R Babaei-Jadidi, A Nateri, E Rakha, S Madhusudan. ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity. Cells Journal, IF 4.326, Oct 2019; PMCID: PMC6848936. DOI: 10.3390/cells8101271. https://pubmed.ncbi.nlm.nih.gov/31635307/
• R Ali, M Alabdullah* (Joint author), A Alblihy, I Miligy, K Mesquita, S Chan, P Moseley, E Rakha, S Madhusudan. PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers. [Journal details incomplete—please confirm journal name, year, and DOI for final formatting].
• K Mesquita, M Alabdullah, M Griffin, M Toss, T Abdel-Fatah, A Alblihy, P Moseley, S Chan, E Rakha, S Madhusudan. ERCC1-XPF deficiency is a predictor of Olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers. Gynecologic Oncology Journal, IF 4.540, May 2019; DOI: 10.1016/j.ygyno.2019.02.014. https://doi.org/10.1016/j.ygyno.2019.02.014
• M Alabdullah, D Ahmad, P Moseley, S Madhusudan, S Chan, E Rakha. The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer. Journal of Obstetrics and Gynaecology, IF 0.807, May 2019; 39(4):522–528. PMID: 30712414. https://pubmed.ncbi.nlm.nih.gov/30712414/
• A Alblihy, R Ali, A Ritchie, C Allegrucci, P Moran, K Mesquita, M Algethami, M Toss, M Alabdullah, I Hickson, N Tatum, J Jeyapalan, A Grabowska, E Rakha, N Mongan, S Madhusudan. Targeting meiotic recombination 11 (MRE11) nuclease for personalisation of epithelial ovarian cancer therapy. Submitted to Nature Cancer (under review).
• D Jerjees, O Negm, M Alabdullah, S Mirza, M Alkaabi, M Hameed, R Abduljabbar, A Muftah, C Nolan, A Green, P Tighe, V Band, I Ellis, E Rakha. The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of Oestrogen receptor and HER2 pathways. Breast Cancer Research and Treatment Journal, IF 3.94, Feb 2015; PMID: 25701120. DOI: 10.1007/s10549-015-3308-4. https://pubmed.ncbi.nlm.nih.gov/25701120/
• D Jerjees, M Alabdullah, M Alkaabi, R Abduljabbar, A Muftah, C Nolan, A Green, I Ellis, E Rakha. ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer. Breast Cancer Research and Treatment Journal, IF 3.94, Aug 2014; PMID: 25085753. DOI: 10.1007/s10549-014-3066-8. https://pubmed.ncbi.nlm.nih.gov/25085753/
• D Jerjees, M Alabdullah, A Green, A Alshareeda, R Macmillan, I Ellis, E Rakha. Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer. Breast Cancer Research and Treatment Journal, IF 3.94, Jun 2014; PMID: 24744091. DOI: 10.1007/s10549-014-2941-7. https://pubmed.ncbi.nlm.nih.gov/24744091/
• M Alabdullah. The clinical utility of laparoscopy in the management of impalpable testes in paediatric age group. Dohuk Medical Journal, Dec 2013; Vol 7(2):1–8. https://www.iasj.net/iasj?func=search&addFilter=utlang:%22English%22&query=kw%3A%22Laparoscopy%22&fromYear=&currentYear=2020&sort=yearAsc&earliestYear=1650&toYear=&filter=year%3A%222013%22

No content available to display!!!

No content available to display!!!